Skip to main content
. 2022 Dec 26;9:74. doi: 10.1186/s40779-022-00430-y

Fig. 2.

Fig. 2

Summary of the recommendations on the monitoring and treatment of sepsis-induced immunosuppression. mHLA-DR monocyte human leukocyte antigen DR, GM-CSF granulocyte–macrophage colony-stimulating factor, Treg regulatory T cell